US 11555064
Treating headache comprising administering an antibody to calcitonin gene-related peptide
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11555064 (Treating headache comprising administering an antibody to calcitonin gene-related peptide) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P25/04